A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : HBV / honeybee venom

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   HBV  (>> Co-occurring Abbreviation)
Long Form:   honeybee venom
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Anti-inflammatory and antioxidative properties of honey bee venom on Freund's Complete Adjuvant-induced arthritis model in rats. FCA, MNL, MPO, NC, OSI, PC, TAS, TOS
2019 Antimutagenic and Synergistic Cytotoxic Effect of Cisplatin and Honey Bee Venom on 4T1 Invasive Mammary Carcinoma Cell Line. FBS
2017 Component Resolved Diagnosis in Hymenoptera Anaphylaxis. CRD, VIT, YJV
2017 Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy. ---
2017 Low virulence potential and invivo transformation ability in the honey bee venom treated Clinostomum complanatum. GST, SOD
2016 Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy. ---
2015 Honeybee (Apis mellifera) Venom Reinforces Viral Clearance during the Early Stage of Infection with Porcine Reproductive and Respiratory Syndrome Virus through the Up-Regulation of Th1-Specific Immune Responses. IFN, IL, PRRS, PRRSV
2015 IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology. ---
2014 Component resolution reveals additional major allergens in patients with honeybee venom allergy. CCD
10  2013 Effect of bee venom on IL-6, COX-2 and VEGF levels in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate. COX-2, EV, i.p, IL-6, PCOS, s.c, VEGF
11  2013 Reactions to honeybee stings: an allergic prospective. ---
12  2012 The major royal jelly proteins 8 and 9 (Api m 11) are glycosylated components of Apis mellifera venom with allergenic potential beyond carbohydrate-based reactivity. CCD, MRJP, sIgE
13  2011 Api m 10, a genuine A.mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts. CCD
14  2010 Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice. BV, HUVECs, LLC, PBML, VEGF
15  2010 Cross-reactive carbohydrate determinants strongly affect the results of the basophil activation test in hymenoptera-venom allergy. BAT, CCD, IC, sIgE, YJV
16  2010 Diagnosis and treatment of allergy to hymenoptera venoms. YJV
17  2010 Double (honeybee and wasp) immunoglobulin E reactivity in patients allergic to Hymenoptera venom: the role of cross-reactive carbohydrates and alcohol consumption. Ig, YJV
18  2004 Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. SARs, VIT
19  2001 Case report of venom immunotherapy for a patient with large local reactions. IT
20  2000 Successful treatment of occupational allergy to bumblebee venom after failure with honeybee venom extract. BBV, VIT
21  1994 Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy. SR, VIT, YJV
22  1994 [Hypersensitivity to honey bee venom]. ---
23  1993 Modulation of alpha 1-acid glycoprotein (AGP) gene induction following honey bee venom administration to adjuvant arthritic (AA) rats; possible role of AGP on AA development. AA, AGP, TNF
24  1991 Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. CH, IT, SRs
25  1988 Low specific IgE, IgG and lymphocyte reactivity in a group of patients developing anaphylaxis following a honey-bee sting. ---
26  1988 Regulation of the immune response to allergens by immunosuppressive allergenic fragments. 1. Peptic fragments of honey bee venom phospholipase A2. PLA2
27  1987 A double-blind study comparing monomethoxy polyethylene glycol-modified honeybee venom and unmodified honeybee venom for immunotherapy. I. Clinical results. IT, mPEG, SR
28  1987 Combination of passive and active immunization in honeybee venom immunotherapy. ---
29  1987 Detailed IgG and IgE antibody patterns during immunotherapy with honey bee venom. PLA
30  1986 A preliminary study of immunotherapy with a monomethoxy polyethylene glycol modified honey bee venom preparation. IT, mPEG
31  1986 IgG and IgE antibody patterns after immunotherapy with monomethoxy polyethyleneglycol modified honey bee venom. mPEG
32  1985 A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom. PEG-HBV
33  1984 Inhibitory effect of honey bee venom on immune complex mediated leukocyte migration into rabbit knee-joints. ---
34  1983 Antibody responses to honey-bee venom and monomethoxy-polyethylene glycol-modified honey-bee venom in mice. ---
35  1983 Honey bee venom specific immunoglobulin G4 in honey bee sting allergic patients and bee keepers. MSPIRA
36  1983 Reduction of interference by specific IgG with a modified microtiter solid-phase radioimmunoassay to measure honeybee venom IgE. MSPRIA
37  1980 Interference in ragweed pollen and honeybee venom radioallergosorbent tests. DEAE, RAST, SRW
38  1979 Evaluation of bee sting allergy by skin tests and serum antibody assays. RAST